Mayfair Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.38M Buy
1,496
+19
+1% +$19.3K 0.48% 41
2025
Q4
$1.6M Buy
1,477
+7
+0.5% +$6.69K 0.62% 38
2025
Q3
$1.12M Buy
1,470
+21
+1% +$15.6K 0.48% 43
2025
Q2
$906K Buy
1,449
+1
+0.1% +$777 0.43% 49
2025
Q1
$1.2M Sell
1,448
-85
-6% -$70.7K 0.69% 33
2024
Q4
$1.18M Buy
1,533
+64
+4% +$53K 0.7% 31
2024
Q3
$1.3M Buy
1,469
+6
+0.4% +$5.39K 0.82% 26
2024
Q2
$1.39M Sell
1,463
-26
-2% -$20.8K 0.94% 25
2024
Q1
$1.16M Buy
1,489
+80
+6% +$56.9K 0.84% 27
2023
Q4
$834K Buy
1,409
+12
+0.9% +$7K 0.71% 31
2023
Q3
$809K Hold
1,397
0.78% 29
2023
Q2
$632K Hold
1,397
0.63% 39
2023
Q1
$523K Sell
1,397
-55
-4% -$18.5K 0.57% 43
2022
Q4
$508K Buy
1,452
+55
+4% +$19.5K 0.65% 40
2022
Q3
$449K Sell
1,397
-550
-28% -$174K 0.63% 42
2022
Q2
$642K Hold
1,947
0.85% 31
2022
Q1
$570K Buy
1,947
+158
+9% +$40.7K 0.73% 35
2021
Q4
$466K Buy
1,789
+35
+2% +$8.87K 0.62% 38
2021
Q3
$394K Hold
1,754
0.6% 44
2021
Q2
$403K Buy
1,754
+34
+2% +$6.83K 0.64% 41
2021
Q1
$319K Hold
1,720
0.57% 45
2020
Q4
$290K Buy
1,720
+14
+0.8% +$2.09K 0.57% 48
2020
Q3
$253K Hold
1,706
0.65% 41
2020
Q2
$280K Buy
+1,706
New +$262K 0.9% 25

Other funds holding LLY

Mayfair Advisory Group's LLY Position: Q1 2026 in Review

Mayfair Advisory Group increased its Eli Lilly (LLY) stake by 1.3% in Q1 2026, buying an estimated $19.3K and bringing the position to 1,496 shares worth $1.38M. The position accounts for 0.48% of the portfolio, ranked #41.

Mayfair Advisory Group first reported a position in LLY in Q2 2020 and has held it in 24 quarters since. The position peaked at $1.6M in Q4 2025. 4,363 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Mayfair Advisory Group held 1,496 shares of Eli Lilly worth $1.38M as of Q1 2026.
  • Mayfair Advisory Group bought 19 Eli Lilly shares in Q1 2026, an estimated $19.3K.
  • Eli Lilly made up 0.48% of Mayfair Advisory Group's portfolio in Q1 2026, its #41 holding.
  • Mayfair Advisory Group first reported a position in Eli Lilly in Q2 2020 and has held it in 24 quarters since.
  • Mayfair Advisory Group's Eli Lilly position peaked at $1.6M in Q4 2025.
  • 4,363 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Mayfair Advisory Group's 13F filing for Q1 2026, filed 21 Apr 2026.